Drugs / Gamma-PN
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT07205289 Background | Oct 2025 → Jan 2026 overdue | pneumococcal infection | GPN Vaccines | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Gamma-PN | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07205289 ↗ |
| Modality | Vaccine | “Killed whole-cell pneumococcal vaccine” NCT07205289 ↗ |
| Route | Intramuscular | “Intramuscular administration 500 mcg” NCT07205289 ↗ |